spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  MRSA  

 HSMN NewsFeed - 16 May 2023
BD Gains 510(k) Clearance of Artificial Intelligence Software for MRSA Diagnostics
Diagnostics FDA
 HSMN NewsFeed - 17 Mar 2022
New Cardinal Health Surgical Drape Helps Reduce Surgical Site Contamination Risk
Devices Surgery Product Launch
 HSMN NewsFeed - 26 Oct 2020
Armata Pharmaceuticals Appoints Mina Pastagia, MD, MS as Vice President of Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Oct 2020
Titan Pharmaceuticals Provides a Strategic & Corporate Update
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jul 2020
MolecuLight Launches i:X(R) Sterile Surgical Sleeve for Imaging of Bacteria in Wounds in a Surgical Setting
Devices Surgery Wound Care Product Launch
 HSMN NewsFeed - 6 Nov 2018
Cumberland Pharmaceuticals To Acquire VIBATIV(R)
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 23 Apr 2018
Theravance Biopharma Reports Positive New Data from Multiple Studies of VIBATIV(R) (telavancin) at 2018 ECCMID(TM) Conference
Biopharmaceuticals
 HSMN NewsFeed - 2 Feb 2018
Appointment of Jonathan E. Gold as Interim Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Dec 2017
Medimetriks Pharmaceuticals, Inc. Receives FDA Approval for Xepi(TM) (ozenoxacin) Cream, 1%, a Novel Topical Antibiotic for Impetigo
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 5 Oct 2017
Vestagen Closes $9.5 Million Financing to Advance Adoption of Its VESTEX(R) Active Barrier Healthcare Uniforms
Devices Venture Capital
 HSMN NewsFeed - 26 Sep 2016
MicuRx Closes $55 Million Series C Financing to Support Development of Next-Generation Antibiotic MRX-I
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 22 Jul 2016
ContraFect Corporation Names Steven C. Gilman, PhD Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jun 2016
Savara Pharmaceuticals Acquires Serendex Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 15 Jun 2016
Allecra Therapeutics Announces €22 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 31 May 2016
Allergan Receives FDA Approval of TEFLARO(R) (ceftaroline fosamil) for Pediatric Patients
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 May 2016
Theravance Biopharma Announces FDA Approval of Expanded Label for VIBATIV(R) (telavancin)
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Mar 2016
Savara Pharmaceuticals Completes $20 Million Round of Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Mar 2015
The Medicines Company Receives European Commission Approval for Three Hospital Acute Care Products: KENGREXAL(TM) (cangrelor), ORBACTIV(R) (oritavancin) and RAPLIXA(TM) (sealant powder)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 26 Jan 2015
Roche receives FDA clearance for next generation cobas MRSA/SA Test
Diagnostics FDA
 HSMN NewsFeed - 23 Jan 2015
The Medicines Company Receives CHMP Positive Opinions for Three Hospital Acute Care Products: KENGREXAL(TM) (cangrelor), ORBACTIV(TM) (oritavancin) and RAPLIXA(TM) (sealant powder)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 5 Dec 2014
Basilea Announces Launch of Antibiotic Zevtera(R) (ceftobiprole medocaril) in Germany
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 18 Nov 2014
AdvanDx Receives FDA 510(k) Clearance for mecA XpressFISH(TM)
Diagnostics FDA
 HSMN NewsFeed - 18 Jul 2014
Durata Therapeutics Announces the U.S. Launch of DALVANCE(TM)
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 5 Jun 2014
ORBACTIV(TM) (Oritavancin) Phase 3 Trial Results Published in New England Journal of Medicine
Biopharmaceuticals
 HSMN NewsFeed - 30 Dec 2013
Cubist Announces FDA Acceptance of Tedizolid New Drug Application with Priority Review
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Dec 2013
Savara Pharmaceuticals Appoints Two New Members to Its Board of Directors
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 15 Nov 2013
Germ-Zapping Robots Use Xenex’s Powerful, Pulsed UV Light to Improve Patient Safety at University Hospital
Devices
 HSMN NewsFeed - 27 Jun 2013
Cepheid Receives FDA Clearance For Updated Xpert MRSA/SA Blood Culture (BC) Test
Diagnostics FDA
 HSMN NewsFeed - 29 Nov 2012
Rib-X Pharmaceuticals Closes First Tranche in $67.5 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Jun 2012
MAQUET Cardiovascular Receives CE Mark For INTERGARD SYNERGY Vascular Graft
Devices Surgery Regulatory
 HSMN NewsFeed - 22 May 2012
Paratek Announces Appointments of Dennis Molnar as Chief Executive Officer and Director and of Dr. Evan Loh as Chief Medical Officer and Chairman of the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Sep 2011
Astellas and Theravance Announce European Marketing Authorization for VIBATIV(R) for Nosocomial Pneumonia Caused by MRSA
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 8 Sep 2011
Nexera Medical, Inc. Announces That It Plans to Submit New Data to the U.S. Food and Drug Administration (FDA) to Amend Its Current 510k Medical Device Clearance to Include Certain Strains of Viruses
Devices
 HSMN NewsFeed - 1 Jul 2011
Merck Receives Approval to Market GARDASIL(R), ZOLINZA(R) and CUBICIN(R) in Japan
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 8 Feb 2011
Oculus Innovative Sciences Receives New FDA 510(k) Clearance for Microcyn-Based Dermatology HydroGel for Management of Atopic Dermatitis, Radiation Dermatitis and Other Skin Dermatoses
Devices Dermatology FDA
 HSMN NewsFeed - 28 Jan 2011
WOUNDS Journal to Publish Study on Efficacy of Novel BIOGUARD Dressings
Devices Wound Care
 HSMN NewsFeed - 20 Dec 2010
NovaDigm Therapeutics Appoints C. Boyd Clarke to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Oct 2010
Forest Announces FDA Approval of Teflaro(TM) (ceftaroline fosamil) for the Treatment of Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infection
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Sep 2010
FDA Advisory Committee Recommends Approval of Forest Laboratories' Ceftaroline Fosamil for the Treatment of Community Acquired Bacterial Pneumonia and Complicated Skin and Skin Structure Infections
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Aug 2010
Advanced Life Sciences Achieves Special Protocol Assessment Agreement With FDA for Restanza in Pneumonia
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Jun 2010
Cepheid Receives FDA Clearance for Xpert SA Nasal Complete, the First Molecular Test for Simultaneous Detection and Differentiation of S. aureus & MRSA Colonization
Diagnostics FDA
 HSMN NewsFeed - 2 Jun 2010
Oculus Innovative Sciences Launches Microcyn(R) Negative-Pressure Wound Therapy Solution for U.S. Market
Devices Wound Care
 HSMN NewsFeed - 10 Mar 2010
Oculus Innovative Sciences Receives First FDA Clearance for Microcyn®-Based HydroGel for Dermatology Market with Claims Including Reduction of Itch and Pain Relief
Devices Wound Care Dermatology FDA
 HSMN NewsFeed - 18 Feb 2010
Derma Sciences Signs Contract With Leading Wound Care Company for Exclusive Distribution of BIOGUARD(TM) Barrier Dressings
Devices Wound Care Distribution
 HSMN NewsFeed - 11 Feb 2010
Excelimmune Receives $1 Million in Series-B Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 Jan 2010
AstraZenenca and CrystalGenomics, Inc. Form Research Collaboration to Develop Novel Anti-Infective Treatments
Biopharmaceuticals
 HSMN NewsFeed - 30 Dec 2009
FDA Issues Complete Response Letter for Ceftobiprole
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Dec 2009
Forest Laboratories Announces Acquisition of Additional Rights Related to NXL 104, a Novel Broad-Spectrum Beta-Lactamase Inhibitor
Biopharmaceuticals Licensing
 HSMN NewsFeed - 5 Nov 2009
Theravance and Astellas Announce the Commercial Launch of VIBATIV(TM) (telavancin) in the United States
Biopharmaceuticals
 HSMN NewsFeed - 8 Oct 2009
Paratek Pharmaceuticals Signs Worldwide License and Commercialization Agreement for PTK 0796, Broad-Spectrum Oral and IV Antibiotic in Phase 3
Biopharmaceuticals Licensing
 HSMN NewsFeed - 1 Oct 2009
Astellas and Theravance Announce Approval of VIBATIV(TM) (telavancin) in Canada for the Treatment of Complicated Skin and Skin Structure Infections
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 16 Sep 2009
Oculus Innovative Sciences Announces New Partnership Agreement with V&M Industries, Inc. for Microcyn(R)-Based OTC Human Wound Care Products
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 10 Sep 2009
Oculus Innovative Sciences Receives Medicare HCPCS Code for Reimbursement of Microcyn(R) Skin & Wound HydroGel
Biopharmaceuticals Wound Care Reimbursement
 HSMN NewsFeed - 24 Aug 2009
New Data Demonstrate Magnetic Resonance Safety of AQUACEL(R) Ag Dressing
Devices Wound Care Radiology
 HSMN NewsFeed - 12 Aug 2009
Forest Laboratories and AstraZeneca to Co-Develop and Commercialize a Late Stage Next Generation Anti-Infective
Biopharmaceuticals
 HSMN NewsFeed - 27 May 2009
Oculus Innovative Sciences Receives FDA Clearance for Microcyn Skin and Wound Gel
Biopharmaceuticals Wound Care FDA
 HSMN NewsFeed - 14 May 2009
ConvaTec Launches New AQUACEL(R) Ag Dressing with Strengthening Fiber
Devices Wound Care
 HSMN NewsFeed - 14 May 2009
Cempra Pharmaceuticals Closes $46 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Apr 2009
Roche to Introduce New LightCycler(R) MRSA Advanced Test in the EU
Diagnostics Regulatory
 HSMN NewsFeed - 31 Mar 2009
Cepheid Announces European Release of First On-Demand Molecular Pre-Surgical Screening Test for Simultaneous Detection of Methicillin-Sensitive and Resistant S. aureus
Diagnostics
 HSMN NewsFeed - 24 Mar 2009
FDA Approves New Indication for Wyeth's TYGACIL (tigecycline) for the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Feb 2009
Derma Sciences Gains FDA Clearance for Novel BIOGUARD(TM) Barrier Dressing with NIMBUS(R) Technology
Devices Wound Care FDA
 HSMN NewsFeed - 24 Feb 2009
CHMP delays European Commission decision process to approve ZEVTERA(TM)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 22 Jan 2009
ConvaTec Announces Expanded Indications for AQUACEL(R) and AQUACEL(R) Ag Dressings in Management of Surgical Wounds
Devices Surgery Wound Care FDA
 HSMN NewsFeed - 13 Jan 2009
The Medicines Company to Acquire Targanta Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 7 Jan 2009
Nomir Medical Announces Second FDA 510(k) Clearance of its Noveon(R) Dual-Wavelength Device
Devices FDA
 HSMN NewsFeed - 7 Jan 2009
DiFUSION Technologies Announces Company Launch Focused on Surgical Site Infections (SSIs)
Devices Orthopaedic Surgery
 HSMN NewsFeed - 26 Nov 2008
FDA Issues Complete Response Letter for Ceftobiprole for Treatment of Complicated Skin Infections
Biopharmaceuticals
 HSMN NewsFeed - 21 Nov 2008
Zevtera(TM) (ceftobiprole medocaril), the novel anti-MRSA broad-spectrum antibiotic, receives a positive opinion from the CHMP
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 22 Oct 2008
Oculus Innovative Sciences Launches Microcyn(R) Wound Care for U.S. Podiatry Market
Devices Wound Care
 HSMN NewsFeed - 1 Oct 2008
Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures
Diagnostics FDA
 HSMN NewsFeed - 29 Sep 2008
Cepheid Receives FDA Clearance for First Rapid On-Demand Molecular Diagnostic Test for MRSA and S. aureus
Diagnostics FDA
 HSMN NewsFeed - 24 Sep 2008
Nice Approves Pradaxa(R)*(Dabigatran Etexilate) - First New Oral Anticoagulant in the UK for Over 50 Years
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 9 Sep 2008
Pfizer Will Withdraw Global Marketing Applications for Dalbavancin to Conduct a New Trial
Biopharmaceuticals Regulatory FDA
 HSMN NewsFeed - 3 Sep 2008
Rib-X Pharmaceuticals, Inc. Appoints Dr. Joseph Amprey of MedImmune Ventures to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Sep 2008
Taking the Gold with Silver: B. Braun Introduces Industry-First Silver Impregnated Needle-Free Luer Access Device
Devices FDA
 HSMN NewsFeed - 28 Jul 2008
Arpida Submits Marketing Authorisation Application for Intravenous Iclaprim in Europe
Biopharmaceuticals
 HSMN NewsFeed - 22 Jul 2008
Nosocomial Vaccines - Minefield or Goldmine?
Biopharmaceuticals
 HSMN NewsFeed - 8 Jul 2008
Daniel B. Dubin, M.D., Joins NanoBio Corp.'s Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jul 2008
BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections
Diagnostics Regulatory
 HSMN NewsFeed - 30 Jun 2008
Ceftobiprole, a new anti-MRSA broad-spectrum antibiotic, receives its first marketing authorization by Health Canada
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 19 Jun 2008
Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections
Biopharmaceuticals
 HSMN NewsFeed - 17 Jun 2008
Randomized Controlled Clinical Trial Shows Derma Sciences MEDIHONEY(TM) Eradicates MRSA From Chronic Venous Ulcers
Devices Wound Care
 HSMN NewsFeed - 4 Jun 2008
Protez Pharmaceuticals to Be Acquired by Novartis
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 May 2008
Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 May 2008
Cardiovascular Researchers Use MEDIHONEY(TM) on Sternal Infections Following Open-Heart Procedures
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 12 May 2008
Cepheid Signs Group Purchasing Contract With Premier Healthcare Alliance, One of the Largest U.S. Group Purchasing Organizations
Diagnostics Group Purchasing
 HSMN NewsFeed - 23 Apr 2008
Oculus Innovative Sciences Appoints Michelle Carpenter, JD, RAC, as Vice President of Regulatory Affairs and Quality
Biopharmaceuticals Wound Care Personnel
 HSMN NewsFeed - 17 Apr 2008
Arpida Provides Comprehensive Overview of Pivotal Phase III Trial Data
Biopharmaceuticals
 HSMN NewsFeed - 9 Apr 2008
Baxter's V-Link Luer-Activated Device With VitalShield Protective Coating Now Available For Hospitals
Devices
 HSMN NewsFeed - 31 Mar 2008
TyRx Pharma, Inc. Announces the Appointment of Gary Young, PharmD, MBA as Vice President, Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Mar 2008
FDA issues Approvable Letter for ceftobiprole, a new anti-MRSA broad-spectrum antibiotic
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Mar 2008
Oculus Innovative Sciences Announces Positive Results From Three Abstracts Evaluating the Use of Microcyn(R) Technology in Diabetic Foot Ulcers
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 11 Mar 2008
I-Flow Leads Infection Prevention Trend by Using Silver with Antimicrobial Properties in Medical Devices
Devices
 HSMN NewsFeed - 28 Feb 2008
TyRx Pharma, Inc. Raises $25 Million in Private Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 Feb 2008
Oculus Innovative Sciences Announces Positive Top-Line Phase II Data with Microcyn(R) Technology in Mildly Infected Diabetic Foot Ulcers
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 26 Feb 2008
Adnavance Technologies Completes $3.7 Million Financing; Appoints Veteran Diagnostics Executive V. Randy White, Ph.D. as Chief Executive Officer
Diagnostics Personnel
 HSMN NewsFeed - 29 Jan 2008
Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System
Diagnostics Regulatory
 HSMN NewsFeed - 22 Jan 2008
NovaBay Pharmaceutical's Investigational New Drug Application (IND) for the Prevention of Catheter Associated Urinary Tract Infections Cleared by FDA
Biopharmacuticals
 HSMN NewsFeed - 17 Jan 2008
Oculus Innovative Sciences, Inc. Appoints Gregg Alton to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Jan 2008
TyRx Pharma, Inc. Announces Food and Drug Administration (FDA) 510(k) Clearance of the AIGIS(Rx)(TM) Cardiac Rhythm Medical Device (CRMD) Anti-Bacterial Envelope, an Innovative Mesh Envelope Designed to Immobilize and Reduce Bacterial Infection of a Pacem
Devices Biopharmaceuticals FDA Cardiology
 HSMN NewsFeed - 3 Jan 2008
Oculus Innovative Sciences Completes Patient Treatment and Follow-up in Its Phase II Clinical Trial in Mildly Infected Diabetic Foot Ulcers
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 2 Jan 2008
BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures
Diagnostics FDA
 HSMN NewsFeed - 21 Dec 2007
Pfizer Receives Approvable Letter from FDA for Dalbavancin
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Dec 2007
Oculus Innovative Sciences Announces Completion of Two Randomized Controlled Clinical Trials of Microcyn(R) Technology in China
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 13 Dec 2007
Puricase(R) (pegloticase) Meets Pre-Specified Primary Efficacy Endpoint in Two Replicate Phase 3 Studies
Biopharmaceuticals
 HSMN NewsFeed - 5 Dec 2007
Theravance Announces Positive Topline Results In Phase 3 Telavancin Hospital-Acquired Pneumonia Program
Biopharmaceuticals
 HSMN NewsFeed - 4 Dec 2007
Cepheid Launches New GeneXpert(R) Tests in Europe for Simultaneous, Rapid Detection of Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus
Diagnostics
 HSMN NewsFeed - 29 Nov 2007
Cepheid and Broadlane Sign Group Purchasing Contract for GeneXpert(R) Systems and Xpert(TM) Molecular Diagnostic Tests, Including Xpert MRSA
Diagnostics Group Purchasing
 HSMN NewsFeed - 19 Nov 2007
Oculus Innovative Sciences Wins Federal Court Ruling in Intellectual Property Rights Litigation
Biopharmaceuticals Litigation
 HSMN NewsFeed - 9 Nov 2007
Baxter Receives 510(k) Clearance From FDA For V-Link With VitalShield, New Antimicrobial Intravascular Technology
Devices FDA
 HSMN NewsFeed - 5 Nov 2007
Microtek Medical Introduces StethoClean
Devices
 HSMN NewsFeed - 24 Oct 2007
FDA Accepts Wyeth's Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
Biopharmaceuticals
 HSMN NewsFeed - 24 Oct 2007
Hospitals Adopt STERIS Advanced Room Sterilization Technology in the Fight Against 'Superbugs'
Devices
 HSMN NewsFeed - 22 Oct 2007
Theravance Receives FDA Approvable Letter for Telavancin for the Treatment of Complicated Skin and Skin Structure Infections
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 Oct 2007
Basilea Announces Positive Top-line Data from Phase III Study of Ceftobiprole in Hospital-Acquired Pneumonia
Biopharmaceuticals
 HSMN NewsFeed - 8 Oct 2007
Dade Behring Receives FDA Clearance for Rapid-Result Gram Positive Microbiology Tests
Diagnostics FDA
 HSMN NewsFeed - 8 Oct 2007
New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients with Diabetic Foot Infections
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 18 Sep 2007
New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients With Complicated Skin Infections, Including MRSA
Biopharmaceuticals
 HSMN NewsFeed - 12 Sep 2007
New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA
Biopharmaceuticals
 HSMN NewsFeed - 6 Sep 2007
Theravance Retains Full Ownership of Gastrointestinal Motility Dysfunction Program and TD-1792 Antibiotic
Biopharmaceuticals Gastroenterology Licensing
 HSMN NewsFeed - 21 Jun 2007
Arpida Receives Approval From US FDA to Initiate a Phase II Trial With iclaprim in Hospital-Acquired, Ventilator and Healthcare-Associated Pneumonia
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Jun 2007
Basilea Announces Submission of Marketing Authorization Application in Europe by Janssen-Cilag International NV for Ceftobiprole, a Novel Anti-MRSA Broad-spectrum Cephalosporin
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 14 Jun 2007
Derma Sciences Receives Health Canada Clearance for API-MED(TM) Antimicrobial Dressings with Active Manuka Honey
Devices Wound Care Regulatory
 HSMN NewsFeed - 31 May 2007
Derma Sciences Announces Preliminary Results of Study Involving Active Manuka Honey at European Wound Management Conference
Wound Care
 HSMN NewsFeed - 18 May 2007
New Drug Application Submitted For Novel Investigational Antibiotic Ceftobiprole
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Apr 2007
BD Announces FDA 510(k) Submission of Two Hour Test to Identify Superbug in Patients with Positive Blood Cultures
Diagnostics FDA
 HSMN NewsFeed - 18 Apr 2007
Cepheid's Xpert(TM) MRSA Test for Methicillin-Resistant Staphylococcus Aureus Receives FDA Clearance
Diagnostics FDA
 HSMN NewsFeed - 22 Mar 2007
Cubist Pharmaceuticals Licenses Rights for Development and Commercialization of CUBICIN in Japan to Merck & Co., Inc.
Biopharmaceuticals Licensing
 HSMN NewsFeed - 12 Mar 2007
3M Health Care Launches Medical Diagnostics Business
Diagnostics
 HSMN NewsFeed - 19 Feb 2007
Basilea Reports Positive Phase III Results for Alitretinoin
Biopharmaceuticals
 HSMN NewsFeed - 14 Feb 2007
3M Expands its Medical Diagnostics Platform with Acquisition of Acolyte Biomedica Ltd.
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 9 Feb 2007
Targanta Announces $70 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Jan 2007
Cepheid and bioMerieux Enter Into Strategic Agreements to Develop and Market Sepsis and MRSA Products
Diagnostics
 HSMN NewsFeed - 10 Jan 2007
Basilea Announces Positive Top-Line Results On Second Pivotal Phase III Ceftobiprole Trial
Biopharmaceuticals
 HSMN NewsFeed - 4 Jan 2007
Elusys Announces Collaborative Research and License Agreement with Pfizer
Biopharmaceuticals Licensing
 HSMN NewsFeed - 19 Dec 2006
Basilea Announces Start of Phase III Program for Isavuconazole, Its Third Investigational Drug to Reach Pivotal Trials
Biopharmaceuticals
 HSMN NewsFeed - 14 Dec 2006
Forest Laboratories Announces Acquisition of Cerexa, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 7 Dec 2006
Basilea to Co-Promote Ceftobiprole
Biopharmaceuticals
 HSMN NewsFeed - 26 Oct 2006
Cepheid Extends European Product Line With Launch of Xpert(TM) MRSA Test for GeneXpert(R) System
Diagnostics
 HSMN NewsFeed - 11 Oct 2006
Immtech Pharmaceuticals Announces Antimicrobial Pipeline Progress
Biopharmaceuticals
 HSMN NewsFeed - 29 Sep 2006
Basilea Reports Excellent Pivotal Data for Ceftobiprole, a Novel Anti-MRSA Broad-spectrum Investigational Antibiotic, at ICAAC
Biopharmaceuticals
 HSMN NewsFeed - 18 Jul 2006
Theravance and Astellas Add Japan to Collaboration on Telavancin, Investigational Antibiotic for Serious Infections
Biopharmaceuticals
 HSMN NewsFeed - 13 Jul 2006
Elusys Therapeutics Completes $23 Million Series D Venture Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 May 2006
Theravance Announces Enrollment of Last Patient in Phase 3 Complicated Skin and Skin Structure Infections Clinical Program With Investigational Antibiotic, Telavancin
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 42

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 42 additional stories matching:
MRSA
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!